News

Filter

Tag: Michael Holtzman

December 10, 2021
Asthma may reduce risk of brain tumors — but how?
Mouse study IDs immune cells as link, points to potential therapeutic approaches.
News Release
August 24, 2021
Why do short-lived lung infections lead to long-lasting lung damage?
Study points to mechanism of post-viral lung damage; suggests targets of intervention.
News Release
May 6, 2021
Obituary: Michael E. Hughes, assistant professor of pulmonary medicine, 41
Neuroscientist advanced understanding of body’s biological clock.
Obituaries
March 8, 2021
Immune cell implicated in development of lung disease following viral infection
Findings could help explain how asthma, COPD, severe COVID-19 are triggered.
News Release
February 23, 2021
New strategy blocks chronic lung disease in mice
Research involving cytokines and how they’re packaged sheds light on inflammation in asthma, COPD, COVID-19.
News Release
August 12, 2020
Drug development for severe respiratory diseases supported with $3.9 million grant
New drug candidate targets asthma, COPD, other progressive lung diseases.
News Release
September 9, 2019
$7.5 million to fund pioneering approaches to respiratory disease
New grants support drug discovery for asthma, COPD, related cancers.
News Release
June 30, 2017
New clues found to common respiratory virus
Discovery provides potential target for vaccines, treatments.
News Release
December 16, 2014
Researchers define viral link to chronic obstructive pulmonary disease
Research is uncovering a link between common viral infections and certain forms of lung disease, leading to potential therapies.
Innovate Magazines
October 24, 2014
Research sheds light on asthma and respiratory viruses
Washington University researchers are studying respiratory viruses to better understand how they contribute to asthma and other conditions.
Innovate Magazines, School of Medicine